Have a personal or library account? Click to login

Risperidone oral disintegrating mini-tablets: A robust-product for pediatrics

Acta Pharmaceutica
Volume 65 (2015): Issue 4 (December 2015)
By:
Open Access
|Dec 2015

References

  1. 1. P. Lennartz and J. B. Mielck, Minitabletting: Improving the compactability of paracetamol powder mixtures, Int. J. Pharm. 173 (1998) 75-85; DOI: 10.1016/S0378-5173(98)00206-3.10.1016/S0378-5173(98)00206-3
    Search in Google Scholar
  2. 2. I . Stoltenberg and J. Breitkreutz, Orally disintegrating mini-tablets (odmts) - a novel solid oral dosage form for paediatric use, Eur. J. Pharm. Biopharm. 78 (2011) 462-469; DOI: 10.1016/j.ejpb. 2011.02.005.
    Search in Google Scholar
  3. 3. K. Wening and J. Breitkreutz, Oral drug delivery in personalized medicine: Unmet needs and novel approaches, Int. J. Pharm. 404 (2011) 1-9; DOI: 10.1016/j.ijpharm.2010.11.001.10.1016/j.ijpharm.2010.11.00121070842
    Search in Google Scholar
  4. 4. D . L. Munday, A comparison of the dissolution characteristics of theophylline from film coated granules and mini-tablets, Drug Dev. Ind. Pharm. 20 (1994) 2369-2379; DOI: 10.3109/03639049409042643.10.3109/03639049409042643
    Search in Google Scholar
  5. 5. M. L. Huang, A. Van Peer, R. Woestenborghs, R. De Coster, J. Heykants, A. A. Jansen, Z. Zylicz, H. W. Visscher and J. H. Jonkman, Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects, Clin. Pharmacol. Ther. 54 (1993) 257-268; DOI:10.1038/clpt.1993.146.10.1038/clpt.1993.1467690693
    Search in Google Scholar
  6. 6. ICH(Q4b) Guideline, General chapters, Annex 6, Step 4. Evaluation and recommendation of pharmacopeial texts for use in the ICH regions on uniformity of dosage units, in: Group, I.E.W. (ed.), ICH Harmonised Tripartite Guideline J.FDA , EMA, US. FDA , USA. 2014; Available from: http:// www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q4B/Step4/Q4B_ Guideline.pdf; last access date July 23, 2015.
    Search in Google Scholar
  7. 7. S. Khan, P. Kataria, P. Nakhat and P. Yeole, Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets, AAPS PharmSciTech. 8 (2007) E127-E133; DOI: 10.1208/pt0802046.10.1208/pt0802046275036117622121
    Search in Google Scholar
  8. 8. I . Mutlu and E. Oktay, Characterization of 17-4 PH stainless steel foam for biomedical applications in simulated body fluid and artificial saliva environments, Mater. Sci. Eng. C, Mater. Biol. Appl. 33 (2013) 1125-1131; DOI: 10.1016/j.msec.2012.12.004.10.1016/j.msec.2012.12.00423827551
    Search in Google Scholar
  9. 9. J . S. P. Daniel, I. P. Veronez, L. L. Rodrigues, M. G. Trevisan and J. S. Garcia, Risperidone - solidstate characterization and pharmaceutical compatibility using thermal and non-thermal techniques, Thermochim. Acta 568 (2013) 148-155; DOI: 10.1016/j.tca.2013.06.032.10.1016/j.tca.2013.06.032
    Search in Google Scholar
  10. 10. R . Canitano and V. Scandurra, Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents, Neuropsychiatr. Dis. Treat. 4 (2008) 723-730; DOI: 10.2147/ ND T.S1450.10.2147/NDT.S1450253653919043516
    Search in Google Scholar
  11. 11. C. C. Sun, Mechanism of moisture induced variations in true density and compaction properties of microcrystalline cellulose, Int. J. Pharm. 346 (2008) 93-101; DOI: 10.1016/j.ijpharm.2007.06.017.10.1016/j.ijpharm.2007.06.01717669609
    Search in Google Scholar
  12. 12. J . G. Osorio and F. J. Muzzio, Effects of powder flow properties on capsule filling weight uniformity, Drug Dev. Ind. Pharm. 39 (2013) 1464-1475; DOI: 10.3109/03639045.2012.728227.10.3109/03639045.2012.72822723902366
    Search in Google Scholar
  13. 13. D . Otter, Milk: Physical and Chemical Properties, in Encyclopedia of Food Sciences and Nutrition (Ed. B. Caballero, L. C. Trugo, P. M. Finglas), 2nd ed., Academic Press, Oxford 2003, pp. 3957-3963.10.1016/B0-12-227055-X/00786-0
    Search in Google Scholar
  14. 14. M. B. Almeida, J. A. Almeida, M. E. Moreira and F. R. Novak, Adequacy of human milk viscosity to respond to infants with dysphagia: Experimental study, J. Appl. Oral Sci. 19 (2011) 554-559; DOI: 10.1590/S1678-77572011000600003.10.1590/S1678-77572011000600003
    Search in Google Scholar
  15. 15. W. H. Schwarz, The rheology of saliva, J. Dent. Res. 66 (1987) 660-666; DOI: 10.1177/00220345870660S209.10.1177/00220345870660S209
    Search in Google Scholar
  16. 16. R . Pabari and Z. Ramtoola, Effect of a disintegration mechanism on wetting, water absorption, and disintegration time of orodispersible tablets, J. Young Pharm. 4 (2012) 157-163; DOI: 10.4103/0975-1483.100021.10.4103/0975-1483.100021
    Search in Google Scholar
  17. 17. A . M. Juppo, Relationship between breaking force and pore structure of lactose, glucose and mannitol tablets, Int. J. Pharm. 127 (1996) 95-102; DOI: 10.1016/0378-5173(95)04203-2. 10.1016/0378-5173(95)04203-2
    Search in Google Scholar
DOI: https://doi.org/10.1515/acph-2015-0038 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 365 - 382
Accepted on: Jul 23, 2015
Published on: Dec 17, 2015
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
risperidone,
mini-tablets,
pediatrics,
optimization design,
disintegration
Related subjects:
Pharmacy,
Pharmacy, other

© 2015 Khalid M. El-Say, Tarek A. Ahmed, Maged F. Abdelbary, Bahaa E. Ali, Bader M. Aljaeid, Ahmed S. Zidan, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 65 (2015): Issue 4 (December 2015)Next article